NO830697L - Homogent menneske-immun-interferon og fremstilling derav - Google Patents

Homogent menneske-immun-interferon og fremstilling derav

Info

Publication number
NO830697L
NO830697L NO830697A NO830697A NO830697L NO 830697 L NO830697 L NO 830697L NO 830697 A NO830697 A NO 830697A NO 830697 A NO830697 A NO 830697A NO 830697 L NO830697 L NO 830697L
Authority
NO
Norway
Prior art keywords
interferon
column
human
immune
active fractions
Prior art date
Application number
NO830697A
Other languages
English (en)
Norwegian (no)
Inventor
Stanley Stein
Richard A Wolfe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO830697L publication Critical patent/NO830697L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO830697A 1982-03-01 1983-02-28 Homogent menneske-immun-interferon og fremstilling derav NO830697L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35344282A 1982-03-01 1982-03-01

Publications (1)

Publication Number Publication Date
NO830697L true NO830697L (no) 1983-09-02

Family

ID=23389118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830697A NO830697L (no) 1982-03-01 1983-02-28 Homogent menneske-immun-interferon og fremstilling derav

Country Status (19)

Country Link
EP (1) EP0087686A3 (enExample)
JP (1) JPS58159417A (enExample)
KR (1) KR840003422A (enExample)
AU (1) AU1181283A (enExample)
DK (1) DK104283A (enExample)
ES (1) ES520164A0 (enExample)
FI (1) FI830557L (enExample)
GB (1) GB2119383A (enExample)
GR (1) GR77910B (enExample)
GT (1) GT198301619A (enExample)
IL (1) IL67978A0 (enExample)
MC (1) MC1499A1 (enExample)
MT (1) MTP924B (enExample)
MW (1) MW783A1 (enExample)
NO (1) NO830697L (enExample)
NZ (1) NZ203364A (enExample)
PT (1) PT76310B (enExample)
ZA (1) ZA83768B (enExample)
ZW (1) ZW4683A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
NO861139L (no) * 1985-03-25 1986-09-26 Schering Corp Stabilt gamma-interferonpreparat.
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
EP0302862A1 (en) * 1986-03-17 1989-02-15 Schering Corporation Treatment of cancers with gamma interferon
IL84170A0 (en) * 1986-10-17 1988-03-31 Interferon Sciences Inc Method for detecting interferon
ATE74517T1 (de) * 1987-01-20 1992-04-15 Schering Corp Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA120527A (en) * 1907-05-18 1909-09-14 James Mccallum Robertson Prepay device for meters
CA120526A (en) * 1909-05-05 1909-09-14 Robert A. Reynolds Internal combustion engine
CA130300A (en) * 1910-08-03 1911-01-03 John W. Ziegler Current wheel
CA154712A (en) * 1914-01-02 1914-03-31 William Francis Fox Photographic process
CA179241A (en) * 1917-03-02 1917-09-11 John Totterdale Container
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Also Published As

Publication number Publication date
AU1181283A (en) 1983-09-08
ES8407499A1 (es) 1984-10-01
PT76310B (en) 1986-02-12
NZ203364A (en) 1986-07-11
DK104283D0 (da) 1983-02-28
GB8305506D0 (en) 1983-03-30
PT76310A (en) 1983-03-01
GT198301619A (es) 1984-08-21
JPS58159417A (ja) 1983-09-21
ZW4683A1 (en) 1983-10-19
MC1499A1 (fr) 1983-11-17
EP0087686A2 (en) 1983-09-07
GR77910B (enExample) 1984-09-25
EP0087686A3 (en) 1985-09-18
MTP924B (en) 1984-05-03
FI830557A0 (fi) 1983-02-18
KR840003422A (ko) 1984-09-08
IL67978A0 (en) 1983-06-15
ES520164A0 (es) 1984-10-01
DK104283A (da) 1983-09-02
FI830557A7 (fi) 1983-09-02
ZA83768B (en) 1983-10-26
GB2119383A (en) 1983-11-16
FI830557L (fi) 1983-09-02
MW783A1 (en) 1984-09-12

Similar Documents

Publication Publication Date Title
Yip et al. Partial purification and characterization of human gamma (immune) interferon.
EP0567554B1 (en) Method for the purification of intact, correctly-folded insulin-like growth factor-1
US6471500B1 (en) Process for producing erythropoietin containing no animal proteins
US4432895A (en) Monomeric interferons
NO830697L (no) Homogent menneske-immun-interferon og fremstilling derav
Lai et al. Chemistry of cholera toxin: the subunit structure
Peumans et al. Isolation and partial characterization of wheat-germ-agglutinin-like lectins from rye (Secale cereale) and barley (Hordeum vulgare) embryos
US5196323A (en) Process for preparing and purifying alpha-interferon
Carra Purification and N-terminal analyses of algal biliproteins
CA1231306A (en) Purification of interferon
Tsuda Purification and characterization of a lectin from rice bran
WETZEL et al. Properties of a human alpha-interferon purified from E. coli extracts
US4765903A (en) Purification of monomeric interferon
NO159610B (no) Fremgangsm te ved rensing av et immuninterferonfrag
US4534906A (en) Removal of impurities from human leukocyte interferon preparations
Kung et al. [29] Purification of recombinant human immune interferon
US4908432A (en) Novel polypeptide having gamma-interferon activity
CA1340281C (en) Process for preparing and purifying alpha-interferon
US4617378A (en) Purification of biologically active human immune interferon
Garattini et al. Human liver alkaline phosphatase, purification and partial sequencing: homology with the placental isozyme
Kenny et al. [64] Purification of human fibroblast interferon produced in the absence of serum by cibacron blue F3GA-agarose and high-performance liquid chromatography
JPWO1992014832A1 (ja) ヒトｂｃｄｆの精製法
EP0396555B1 (en) Purification of monomeric interferon
MIYATA et al. Pruification of Natural Human Interferon-Gamma by Antibody Affinity Chromatography: Analysis of Constituent Protein Species in the Dimers
Friesen et al. [63] Purification of human fibroblast interferon by high-performance liquid chromatography